Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
Top Cited Papers
- 1 March 2018
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 286 (3), 992-999
- https://doi.org/10.1148/radiol.2017170053
Abstract
To evaluate the effect of middle meningeal artery (MMA) embolization on chronic subdural hematoma (CSDH) and compare the treatment outcomes of MMA embolization and conventional treatment. All consecutive patients 20 years or older with CSDH were assessed for eligibility. CSDHs with a focal location, a thickness of 10 mm or less, no mass effect, or underlying conditions were excluded. Seventy-two prospectively enrolled patients with CSDH underwent MMA embolization (embolization group; as the sole treatment in 27 [37.5%] asymptomatic patients and with additional hematoma removal for symptom relief in 45 [62.5%] symptomatic patients). For comparison, 469 patients who underwent conventional treatment were included as a historical control group (conventional treatment group; close, nonsurgical follow-up in 67 [14.3%] and hematoma removal in 402 [85.7%] patients). Primary outcome was treatment failure defined as a composite of incomplete hematoma resolution (remaining or reaccumulated hematoma with thickness > 10 mm) or surgical rescue (hematoma removal for relief of symptoms that developed with continuous growth of initial or reaccumulated hematoma). Secondary outcomes included surgical rescue as a component of the primary outcome and treatment-related complication for safety measure. Six-month outcomes were compared between the study groups with logistic regression analysis. Spontaneous hematoma resolution was achieved in all of 27 asymptomatic patients undergoing embolization without direct hematoma removal. Hematoma reaccumulation occurred in one (2.2%) of 45 symptomatic patients receiving embolization with additional hematoma removal. Treatment failure rate in the embolization group was lower than in the conventional treatment group (one of 72 patients [1.4%] vs 129 of 469 patients [27.5%], respectively; adjusted odds ratio [OR], 0.056; 95% confidence interval [CI]: 0.011, 0.286; P = .001). Surgical rescue was less frequent in the embolization group (one of 72 patients [1.4%] vs 88 of 469 patients [18.8%]; adjusted OR, 0.094; 95% CI: 0.018, 0.488; P = .005). Treatment-related complication rate was not different between the two groups (0 of 72 patients vs 20 of 469 patients [4.3%]; adjusted OR, 0.145; 95% CI: 0.009, 2.469; P = .182). MMA embolization has a positive therapeutic effect on CSDH and is more effective than conventional treatment. © RSNA, 2017Keywords
Funding Information
- Korea Health Industry Development Institute (HI16C1197)
- Seoul National University Bundang Hospital (B-1104125005)
This publication has 28 references indexed in Scilit:
- Effects of atorvastatin on chronic subdural hematomaMedicine, 2017
- Perindopril and residual chronic subdural hematoma volumes six weeks after burr hole surgery: A randomized trialClinical Neurology and Neurosurgery, 2014
- PlGF and sVEGFR-1 in chronic subdural hematoma: implications for hematoma developmentJournal of Neurosurgery, 2013
- The role of corticosteroids in the management of chronic subdural hematoma: a systematic reviewEuropean Journal of Neurology, 2012
- Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective studyInflammation Research, 2012
- Non-surgical primary treatment of chronic subdural haematoma: Preliminary results of using dexamethasoneBritish Journal of Neurosurgery, 2005
- Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective studyJournal of Neurosurgery, 2004
- The “Subdural” SpaceNeurosurgery, 1993
- Subdural compartment in pig: A morphologic study with blood and horseradish peroxidase infused subdurallyThe Anatomical Record, 1991
- Role of local hyperfibrinolysis in the etiology of chronic subdural hematomaJournal of Neurosurgery, 1976